Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/AMRUTANJAN stock hub

NSE/AMRUTANJAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/AMRUTANJANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.9B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/AMRUTANJAN

In the news

Latest news · NSE/AMRUTANJAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E27.4

P25 24.8P50 35.9P75 56.9

ROE16.6

P25 6.3P50 13.6P75 18.1

ROIC25

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/AMRUTANJAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

INR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	737
Employees Change	103%
Employees Change Percent	16.25
Enterprise value	INR 15.5B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE098F01031
Last refreshed	2026-05-10
Market cap	INR 15.9B
Price	INR 545
Price currency	INR
Rev Per Employee	7,057,348.71x
Sector	Healthcare
Sic	2834
Symbol	nse/AMRUTANJAN
Website	https://www.amrutanjan.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.65%
EV Earnings	26.8x
EV/EBIT	19.56x
EV/EBITDA	18.12x
EV/FCF	-81.53x
EV/Sales	2.98x
FCF yield	-1.2%
P/B ratio	4.29x
P/E ratio	27.39x
P/S ratio	3.05x
PE Ratio10 Y	37.83x
PE Ratio3 Y	40.79x
PE Ratio5 Y	40.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.25%
EBITDA Margin	16.47%
Gross margin	53.02%
Gross Profit	INR 2.8B
Gross Profit Growth	23.65%
Gross Profit Growth Q	33.1%
Gross Profit Growth3 Y	12.76%
Gross Profit Growth5 Y	7.75%
Net Income	INR 579.2M
Net Income Growth	13.93%
Net Income Growth Q	6.69%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	13.29%
Net Income Growth5 Y	-1.09%
Pretax Margin	14.97%
Profit Margin	11.14%
Profit Per Employee	INR 785,859
Profitable Years	20
ROA	10.66
Roa5y	10.11
ROCE	20.73
ROE	16.62
Roe5y	18.19
ROIC	24.99
Roic5y	48.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.78%
Cagr15y	15.74%
Cagr1y	-19.28%
Cagr3y	-2.51%
Cagr5y	-2.2%
Div CAGR10	9.84%
Div CAGR3	0%
Div CAGR5	23.52%
EPS Growth	13.94
EPS Growth Q	6.74
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth3 Y	13.69
EPS Growth5 Y	-0.88
OCF Growth	-29.34%
OCF Growth10 Y	20.23%
OCF Growth3 Y	21.24%
OCF Growth5 Y	-16.92%
Revenue Growth	15.08x
Revenue Growth Q	13.97x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	11.05x
Revenue Growth5 Y	9.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.12
Assets	INR 5.1B
Cash	INR 364M
Current Assets	INR 2.9B
Current Liabilities	INR 1.3B
Debt	INR 17.8M
Debt EBITDA	INR 0.02
Debt Equity	INR 0
Debt FCF	INR -0.09
Equity	INR 3.7B
Interest Coverage	406.8
Liabilities	INR 1.4B
Long Term Assets	INR 2.2B
Long Term Liabilities	INR 124.7M
Net Cash	INR 346.2M
Net Cash By Market Cap	INR 2.18
Net Cash Growth	-82.08%
Net Debt EBITDA	INR -0.4
Net Debt Equity	INR -0.09
Tangible Book Value	INR 3.7B
Tangible Book Value Per Share	INR 127
WACC	6.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.31
Inventory Turnover	7.56
Net Working Capital	INR 1.3B
Quick ratio	0.77
Working Capital	INR 1.7B
Working Capital Turnover	INR 2.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 4.6
Dividend Years	22
Dividend Yield	0.84%
Ex Div Date	2026-02-06
Last Dividend	INR 1
Payout Frequency	Quarterly
Payout Ratio	22.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	154.23%
1Y total return	-19.27%
200-day SMA	650.9
3Y total return	-7.35%
50-day SMA	550.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-10.54%
All Time High	1,024.6
All Time High Change	-46.81%
All Time High Date	2021-11-08
All Time Low	42.21
All Time Low Change	1,191.16%
All Time Low Date	2009-11-30
ATR	19.29
Beta	0.41
Ch YTD	-18.48
High	570
High52	791
High52 Date	2025-09-08
High52ch	-31.1%
Low	543
Low52	486
Low52 Date	2026-03-30
Low52ch	12.14%
Ma50ch	-1.02%
Price vs 200-day SMA	-16.26%
RSI	47.66
RSI Monthly	40.88
RSI Weekly	38.88
Sharpe ratio	-0.9x
Sortino ratio	-1.12
Total Return	0.83%
Tr YTD	-18.35
Tr15y	795.71%
Tr1m	6.49%
Tr1w	-4.87%
Tr3m	-14.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 793.3M
Operating Income Growth	48.96
Operating Income Growth Q	19.24
Operating Income Growth3 Y	23.76
Operating Income Growth5 Y	2.02
Operating margin	15.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,351,076%
Net Borrowing	-4,957,000
Shares Insiders	27.58%
Shares Institutions	13.93%
Shares Qo Q	0.04%
Shares Yo Y	0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -181M
Average Volume	30,755.75x
Bv Per Share	128
CAPEX	INR -550M
Ch10y	139.4
Ch15y	671.3
Ch1m	6.49
Ch1w	-4.87
Ch1y	-19.78
Ch3m	-14.04
Ch3y	-9.2
Ch5y	-13.4
Ch6m	-22.97
Change	-2.34%
Change From Open	-1.8
Close	558.1
Days Gap	-0.55
Depreciation Amortization	63,190,000
Dollar Volume	9,735,880
Earnings Date	2026-05-08
EBIT	INR 793.3M
EBITDA	INR 856.5M
EPS	INR 20.03
F Score	4
FCF	INR -190.4M
FCF EV Yield	-1.23x
Financing CF	-136,219,000
Fiscal Year End	March
Founded	1,893
Graham Number	238.59397
Graham Upside	-56.22
Income Tax	INR 199.7M
Investing CF	-212,287,000
Is Primary Listing	0
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2018-04-13
Last Split Type	Forward
Lynch Fair Value	INR 99.47
Lynch Upside	-81.75
Ma150	630.5
Ma150ch	-13.56%
Ma20	556.4
Ma20ch	-2.05%
Net CF	11,171,000
Next Earnings Date	2026-05-22
Open	555
P OCF Ratio	44.11
Payment Date	2026-03-05
Position In Range	7.41
Ppne	1,552,872,000
Price Date	2026-05-08
Price EBITDA	INR 18.52
Ptbv Ratio	4.31
Relative Volume	0.58x
Revenue	5,201,266,000x
SBC By Revenue	-0.18x
Share Based Comp	-9,342,000
Tax By Revenue	3.84x
Tax Rate	25.64%
Tr6m	-22.74%
Volume	17,864

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/AMRUTANJAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$4.60 annual per share

Payout ratio

+23.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+23.5%

0 consecutive years of growth

Total shareholder yield

+0.8%

Next ex-dividend date: 2026-02-06

Performance

NSE/AMRUTANJAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/AMRUTANJAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.9%

Share of float held by funds and institutions

Insider ownership

+27.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/AMRUTANJAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.7

Neutral momentum band

Price vs 200-day MA

-16.3%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

-0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/AMRUTANJAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/AMRUTANJAN stock rating?

nse/AMRUTANJAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/AMRUTANJAN analysis?

The full report lives at /stocks/nse/AMRUTANJAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/AMRUTANJAN?

The latest report frames nse/AMRUTANJAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/AMRUTANJAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.